UTHR

United Therapeutics CorporationNASDAQHealthcare

$564.81-0.96%ClosedMarket Cap: $24.75B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-31	HC Wainwright & Co.	—	Buy	—
2026-03-31	B of A Securities	—	Neutral	—
2026-03-31	Wells Fargo	—	Equal Weight	—
2026-03-30	TD Cowen	—	Buy	—
2026-03-12	Cantor Fitzgerald	—	Overweight	—
2026-03-05	UBS	—	Buy	—
2026-02-26	Wells Fargo	—	Equal Weight	—
2026-02-26	RBC Capital	—	Outperform	—
2026-02-26	TD Cowen	—	Buy	—
2026-02-26	Oppenheimer	—	Outperform	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$32.95	$3.71B	10
Sun Dec 31	$38.67	$4.26B	10
Mon Dec 31	$46.47	$5.02B	4
Tue Dec 31	$53.13	$5.79B	4